Zogenix, Inc. has expanded its senior leadership team to support of the planned launch of Zohydro ER (hydrocodone bitartrate) extended-release capsules in March 2014. Bradley S. Galer, M.D., has been appointed executive vice president and chief medical officer. Prior to joining the company, Dr. Galer served as president of the Pain Group at Nuvo Research, where he oversaw the strategy and operations, including commercialization, drug development activities, business development and licensing opp...